| 摘要 |
<p>A method and therapeutic agent for at least partially inhibiting vascularization of a developing solid tumor. The therapeutic agent comprises polysaccharide toxin, a GBS toxin, produced by group B β-hemolytic Streptococcus bacteria. The GBS agent is in a purified, toxin-active form which can be parenterally administered in an amount effective for vascularization inhibition.</p> |
